US FDA approves SpringWorks Therapeutics' non-cancerous tumor treatment

SpringWorks Therapeutics

27/11/2023 22:40

Nov 27 (Reuters) - The U.S. Food and Drug Administration
(FDA) on Monday approved SpringWorks Therapeutics'  SWTX.O  drug
for treating a type of non-cancerous soft-tissue tumor in
adults.

 (Reporting by Pratik Jain in Bengaluru; Editing by Shilpi
Majumdar)
 ((Pratik.Jain@thomsonreuters.com;))